Myomo, Inc. (NYSE MKT: MYO) (“Myomo” or the “Company”), a commercial stage medical robotics company, today announced that its Chairman and Chief Executive Officer, Paul R. Gudonis, and its Chief Financial Officer, Ralph Goldwasser, will present at the 19th Annual Rodman & Renshaw Global Investment Conference at the Lotte New York Palace Hotel in New York City. The presentation will take place at 10:00 A.M. EDT on Tuesday, September 12, 2017.
In addition, any investors attending the conference that wish to meet with Mr. Gudonis for a one-on-one meeting should contact Lily Khaykina at lk@rodmanevents.com.
About Myomo
Myomo, Inc. is a commercial stage medical
robotics Company that offers expanded mobility for those suffering from
neurological disorders and upper limb paralysis. Based on patented
technology developed at MIT and the Company, Myomo develops and markets
the MyoPro® product line of lightweight, non-invasive, powered arm
braces to restore function in the paralyzed or weakened arms and hands
of individuals that have suffered a stroke, spinal cord or nerve injury
such as brachial plexus injury, or other neuromuscular disability such
as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is
provided through clinical relationships with VA medical centers, leading
rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”)
practices. Several hundred have been successfully used by patients. It
is the only device that, sensing a patient’s own neurological signals
through non-invasive sensors on the arm, can restore their ability to
use their arms and hands so that they can return to work, live
independently and reduce their cost of care. Myomo is headquartered in
Cambridge, Massachusetts, with sales and clinical professionals across
the U.S. For more information, please visit www.myomo.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170905005179/en/
Contacts:
ir@myomo.com
or
Investor
Relations:
PCG Advisory
Vivian Cervantes, 212-554-5482
vivian@pcgadvisory.com
or
Public
Relations:
Greenough
Rachel Robbins, 617-275-6521
rrobbins@greenough.biz